(Q53648349)

16 May 2018

title

Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization. (English)

1 reference

16 May 2018

0 references

Gal Bitan

1

1 reference

16 May 2018

Sabrina S Vollers

series ordinal

2

1 reference

16 May 2018

David B Teplow

series ordinal

3

1 reference

16 May 2018

language of work or name

English

0 references

publication date

2 July 2003

1 reference

16 May 2018

Journal of Biological Chemistry

published in

1 reference

16 May 2018

volume

278

1 reference

16 May 2018

page(s)

34882-34889

1 reference

16 May 2018

issue

37

1 reference

16 May 2018

Mechanisms of amyloid deposition in Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Amyloidosis in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Beta -amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Protofibrils of amyloid beta-protein inhibit specific K+ currents in neocortical cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Scope, limitations and mechanistic aspects of the photo-induced cross-linking of proteins by water-soluble metal complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Structural and kinetic features of amyloid beta-protein fibrillogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Hypothesis: amyloid beta-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Truncating the amyloid cascade hypothesis: the role of C-terminal Abeta peptides in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Kinetics of aggregation of synthetic beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Lipophilicity of amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Structural and dynamical analysis of the hydration of the Alzheimer's beta-amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300825200

21 January 2018

Identifiers

DOI

10.1074/JBC.M300825200

1 reference

16 May 2018

PubMed ID

12840029

1 reference

16 May 2018